Antibiotic Susceptibility Testing Disc Recall Due to Accuracy Concerns
BD BBL Sensi Disc Chloramphenicol test discs may have accuracy and quality control failures during antibiotic susceptibility testing. This could cause delayed results or inappropriate antibiotic selections.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II medical device recall involving diagnostic inaccuracy with potential for adverse diagnostic outcomes. No illnesses or injuries have been reported; the hazard is theoretical. Per the rubric, risk-of-harm products without reported injury receive a score of 3.
Plain-English summary
Becton Dickinson & Co. is recalling BD BBL Sensi Disc Chloramphenicol-30 ug, a diagnostic product used for in vitro antibiotic susceptibility testing. The recall encompasses approximately 2.3 million units across multiple lot numbers, distributed nationwide and internationally.
The discs may have reproducibility, accuracy, and quality control failures during antibiotic susceptibility testing for H. influenzae. These failures could cause product discard, delayed test results, or inaccurate diagnostic outcomes.
Potential adverse effects include diagnostic delays, selection of inappropriate antibiotics, or extended duration of antibiotic exposure during the treatment process. Clinical laboratories and healthcare facilities using affected product lots should be aware of this Class II recall.
The recalled product
- Product
- BD BBL Sensi Disc Chloramphenicol- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 230733¿and 231274¿
- Manufacturer
- Becton Dickinson & Co.
- Affected units
- 2,363,168
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 30 recalled by Becton Dickinson & Co. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Becton Dickinson & Co.
See all →- ModerateBD GasPak EZ Campy Pouch System Recall for Below-Specification Gas Production
FDA (Devices) · 2026-05-06
- ModerateBD GasPak EZ CO2 Pouch System gas generating sachets underperforming
FDA (Devices) · 2026-05-06
- ModerateLaboratory cuvette arrays recalled over barcodes the analyser cannot read
FDA (Devices) · 2025-11-19
- HighAutomated microbiology systems recalled after service credentials were accessed by unauthorized actor
FDA (Devices) · 2025-10-29
- HighBlood culture systems recalled after service credentials were accessed by unauthorized actor
FDA (Devices) · 2025-10-29
Same hazard · qc failure
See all →- HighHelix Elite Quality Control Material Recalled for Delayed Detection and QC Failure
FDA (Devices) · 2025-04-02
- HighAntibiotic Susceptibility Test Discs Recalled for Accuracy and QC Failures
FDA (Devices) · 2024-02-14
- HighAntibiotic susceptibility test discs recalled for accuracy and quality failures
FDA (Devices) · 2024-02-14
- HighBD BBL Sensi Disc Meropenem testing discs recalled for accuracy failures
FDA (Devices) · 2024-02-14
- HighMedical Device Recall: BD BBL Cefaclor Antibiotic Susceptibility Test Disc
FDA (Devices) · 2024-02-14